AngioDynamics, Inc.

NasdaqGS:ANGO Stok Raporu

Piyasa değeri: US$310.9m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

AngioDynamics Yönetim

Yönetim kriter kontrolleri 2/4

AngioDynamics' CEO'su Jim Clemmer, Apr2016 tarihinde atandı, in görev süresi 8.5 yıldır. in toplam yıllık tazminatı $ 5.01M olup, şirket hissesi ve opsiyonları dahil olmak üzere 15.6% maaş ve 84.4% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.91% ine doğrudan sahiptir ve bu hisseler $ 2.87M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 6.3 yıl ve 8.6 yıldır.

Anahtar bilgiler

Jim Clemmer

İcra Kurulu Başkanı

US$5.0m

Toplam tazminat

CEO maaş yüzdesi15.6%
CEO görev süresi8.5yrs
CEO sahipliği0.9%
Yönetim ortalama görev süresi6.3yrs
Yönetim Kurulu ortalama görev süresi8.6yrs

Son yönetim güncellemeleri

Recent updates

AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Jul 19
AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified

Jul 18
Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified

AngioDynamics: A Story To Monitor

May 14

A Leaner AngioDynamics Is A High-Risk Execution-Driven Story

Apr 09

AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

Apr 06
AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

AngioDynamics: Restructuring Initiative May Not Go Far Enough

Jan 14

AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Oct 12
AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

Mar 31
AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

AngioDynamics Non-GAAP EPS of -$0.06 misses by $0.04, revenue of $81.5M misses by $1.93M, reaffirms FY guidance

Oct 06

AngioDynamics: Lack Of Upside Capture Remains, Continue To Hold

Sep 29

Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

Sep 02
Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

AngioDynamics Non-GAAP EPS of $0.01 in-line, revenue of $87M beats by $4.09M

Jul 12

AngioDynamics Shows Progress In Still-Challenging Times

Apr 08

CEO Tazminat Analizi

Jim Clemmer'un ücretlendirmesi AngioDynamics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Aug 31 2024n/an/a

-US$243m

May 31 2024US$5mUS$783k

-US$184m

Feb 29 2024n/an/a

-US$192m

Nov 30 2023n/an/a

-US$14m

Aug 31 2023n/an/a

US$6m

May 31 2023US$4mUS$756k

-US$52m

Feb 28 2023n/an/a

-US$37m

Nov 30 2022n/an/a

-US$33m

Aug 31 2022n/an/a

-US$33m

May 31 2022US$6mUS$736k

-US$27m

Feb 28 2022n/an/a

-US$40m

Nov 30 2021n/an/a

-US$38m

Aug 31 2021n/an/a

-US$34m

May 31 2021US$4mUS$720k

-US$32m

Feb 28 2021n/an/a

-US$169m

Nov 30 2020n/an/a

-US$171m

Aug 31 2020n/an/a

-US$170m

May 31 2020US$3mUS$716k

-US$167m

Feb 29 2020n/an/a

-US$7m

Nov 30 2019n/an/a

-US$6m

Aug 31 2019n/an/a

-US$7m

May 31 2019US$3mUS$687k

-US$11m

Feb 28 2019n/an/a

-US$34m

Nov 30 2018n/an/a

-US$16m

Aug 31 2018n/an/a

-US$12m

May 31 2018US$3mUS$643k

-US$6m

Tazminat ve Piyasa: Jim 'nin toplam tazminatı ($USD 5.01M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 2.40M ).

Tazminat ve Kazançlar: Jim şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Jim Clemmer (60 yo)

8.5yrs

Görev süresi

US$5,005,971

Tazminat

Mr. James C. Clemmer, also known as Jim, has been the Chief Executive Officer, President and a Director of AngioDynamics, Inc. since joining it on April 04, 2016. Mr. Clemmer served as Group President of t...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
James Clemmer
CEO, President & Director8.5yrsUS$5.01m0.91%
$ 2.8m
Stephen Trowbridge
Executive VP & CFO5yrsUS$1.82m0.28%
$ 873.0k
Chad Campbell
Senior VP and GM of Global Vascular Access & Oncology Business Unit8.4yrsUS$1.01m0.18%
$ 556.1k
Warren Nighan
Senior Vice President of Regulatory Affairs7.5yrsUS$995.08k0.083%
$ 258.7k
Laura Piccinini
Senior VP & GM of Endovascular Therapies and International3.3yrsUS$1.23m0.14%
$ 428.4k
Saleem Cheeks
Vice President of Communications4.7yrsVeri yokVeri yok
Benjamin Davis
Senior Vice President of Business Development & Strategy9.6yrsVeri yokVeri yok
Marna Bronfen-Moore
Senior Vice President of Human Resources5.1yrsVeri yokVeri yok
Kim Seabury
Senior Vice President of Information Technology13.1yrsVeri yokVeri yok
Juan Serna
Senior Vice President of Scientific & Clinical Affairs3.8yrsVeri yokVeri yok

6.3yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: ANGO 'un yönetim ekibi deneyimli ve deneyimlidir ( 6.3 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
James Clemmer
CEO, President & Director8.5yrsUS$5.01m0.91%
$ 2.8m
Jan Reed
Independent Director7.9yrsUS$225.11k0.21%
$ 668.3k
Wesley Johnson
Independent Director17.8yrsUS$234.81k0.30%
$ 917.1k
Howard Donnelly
Independent Non-Executive Chairman20.6yrsUS$262.01k0.37%
$ 1.1m
Eileen Auen
Independent Director8.8yrsUS$229.13k0.21%
$ 665.9k
Michael Dake
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Frank Veith
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Thomas Sos
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Stephen Kee
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
John Kaufman
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Jacob Cynamon
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Karen Licitra
Independent Director5.3yrsUS$224.51k0.18%
$ 556.6k

8.6yrs

Ortalama Görev Süresi

63.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ANGO 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.6 yıldır).